Weiss Michael S
SEC-identified person · CIK 1038977 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Fortress Biotech, Inc. [CNDO] | Director · See Remarks | filed 2013 - 2026 |
| TG Therapeutics, INC. TGTXD | Director · See Remarks | filed 2012 - 2026 |
| Checkpoint Therapeutics, Inc. CKPT | Director · Exec. Chairman of the Board | filed 2016 - 2025 |
| Mustang BIO, INC. MBIO | Director · Exec. Chairman of the Board | filed 2017 - 2023 |
| Avenue Therapeutics, INC. ATXI | Director | filed 2017 - 2018 |
| Olympic Cascade Financial Corp OLYD.OB | Director | filed 2010 - 2016 |
| Origo Acquisition Corp OACQ | Director · Co-Chairman of the Board | filed 2014 - 2014 |
| Keryx Biopharmaceuticals INC KERX | Director · Chief Executive Officer | filed 2006 - 2010 |
| Robeco Sage Triton Fund LLC [N/A] | Director | filed 2009 - 2009 |
| XTL Biopharmaceuticals LTD XTLB | Director | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.